SAScion Asset Management, LLC

Institutional investor · Portfolio as of Q2 2024No 13F holdings reported for quarters after Q3 2025.

Top Holdings10 positions

Checking export access…
Activity:
BABABABA
ADR

ALIBABA GROUP HOLDING LTD

155,000$11.2M21.3%$74.77-5.31%
4 qtrssince 2023-Q3
Increased
69

SHIFT4 PMTS INC

100,000$7.3M14.0%$73.350.00%
1 qtr
New
87

MOLINA HEALTHCARE INC

24,530$7.3M13.9%$297.300.00%
1 qtr
New
87
BIDUBIDU
ADR

BAIDU INC - SPON ADR

75,000$6.5M12.4%$96.51-10.39%
2 qtrssince 2024-Q1
Increased
86
JDJD
ADR

JD.COM INC-ADR

250,000$6.5M12.3%$26.73-6.09%
4 qtrssince 2023-Q3
Decreased
0
1.1M$5.5M10.5%——
1 qtr
New
86

THE REALREAL INC

1M$3.2M6.1%$2.87+11.29%
6 qtrssince 2023-Q1
Decreased
0

UNITED INS HLDGS CORP

251,892$2.7M5.1%$8.75+9.11%
3 qtrssince 2023-Q4
Unchanged
0
OLPXOLPXDelisted

OLAPLEX HLDGS INC

995,250$1.5M2.9%$1.540.00%
1 qtr
New
69

BIOATLA INC

633,959$868,5241.7%$1.37+9.49%
1 qtr
New
60
$52.5M
Reported value
10
Positions
Q2 2024
Filing
HI score · 1.0/5
Quarterly 13F Value Change
+130%Q1'23$106.9M+4%Q2'23$111.4M-61%Q3'23$43.9M+115%Q4'23$94.6M+9%Q1'24$103.5M-49%Q2'24$52.5M
Activity profile
$ moved · Q2'24
New21%Increased4%Decreased5%Exited69%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.3 years
<1Q40%1-4Q20%1-2Y20%2Y+20%

Scion Asset Management, LLC reported holdings worth $52.5M across 10 positions as of Q2 2024. Top holdings: BABA (21.3%), FOUR (14.0%), MOH (13.9%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1/5.0.

Q2 2024 Summary

Active quarter - 5 new positions, 11 exits, 2 increased. Top move: FOUR (NEW, conviction 87). Portfolio: $52M across 10 positions.

Top holdings by portfolio weight

Total AUM$52M
BABA21.26%
FOUR13.97%
MOH13.89%
BIDU12.36%
JD12.31%
HPPN10.49%
REAL6.08%
ACIC5.06%
OLPX2.92%
BCAB1.65%

Portfolio allocation by GICS sector

Sectors6
Consumer Cyclical42.57%
Healthcare15.55%
Technology13.97%
Communication Services12.36%
Unknown10.49%
Financial Services5.06%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Consumer Cyclical, Healthcare, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score

No 13F holdings reported for quarters after Q3 2025.

Weak(1.0 / 5.0)
Holdings P&LNo data
Conviction50
Concentration0
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used